written on 28.05.2014

Boehringer to pay $650M to wrap up thousands of Pradaxa lawsuits


Boehringer Ingelheim&nbsp;has agreed to pay $650 million to wrap up thousands of lawsuits claiming&nbsp;Pradaxa, an&nbsp;<a href="http://www.fiercepharma.com/tags/anticoagulant">anticoagulant</a>, caused serious–even fatal–bleeding in some patients. The deal comes just weeks after the FDA completed a safety review of the drug, concluding that it was as safe as the older drug it seeks to replace,&nbsp;warfarin.